Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE 16 WILSON : revenue, balance sheet and financial ratios

SELARL PHARMACIE 16 WILSON is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ANTIBES (06600), this company of category PME shows in 2016 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE 16 WILSON (SIREN 813975679)
Indicator 2018 2016
Revenue N/C 1 109 884 €
Net income 124 336 € -33 604 €
EBITDA N/C -23 198 €
Net margin N/C -3.0%

Revenue and income statement

In 2018, SELARL PHARMACIE 16 WILSON generates positive net income of 124 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

124 336 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 310%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory.

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

310.121%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

21.919%

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

67.6%

Solvency indicators evolution
SELARL PHARMACIE 16 WILSON

Sector positioning

Debt ratio
310.12 2018
2016
2018
Q1: 40.91
Med: 114.61
Q3: 266.0
Average

In 2018, the debt ratio of SELARL PHARMACIE 16 WILSON (310.12) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
21.92% 2018
2016
2018
Q1: 21.63%
Med: 38.41%
Q3: 58.07%
Average

In 2018, the financial autonomy of SELARL PHARMACIE 16 WILSON (21.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-27.93 years 2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Excellent

In 2016, the repayment capacity of SELARL PHARMACIE 16 WILSON (-27.93) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 176.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

176.008

Liquidity indicators evolution
SELARL PHARMACIE 16 WILSON

Sector positioning

Liquidity ratio
176.01 2018
2016
2018
Q1: 118.21
Med: 162.86
Q3: 228.31
Good +20 pts over 2 years

In 2018, the liquidity ratio of SELARL PHARMACIE 16 WILSON (176.01) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-55.92x 2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.31x
Watch

In 2016, the interest coverage of SELARL PHARMACIE 16 WILSON (-55.9x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 157 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 419 days. Excellent situation: suppliers finance 262 days of the operating cycle (retail model).

Operating WCR (2018) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2018) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

157 j

Supplier credit (2018) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

419 j

Inventory turnover (2018) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE 16 WILSON

Positioning of SELARL PHARMACIE 16 WILSON in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 177 transactions of similar company sales in 2018, the value of SELARL PHARMACIE 16 WILSON is estimated at 1 565 501 € (range 1 166 785€ - 2 574 884€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2018
177 transactions
1166k€ 1565k€ 2574k€
1 565 501 € Range: 1 166 785€ - 2 574 884€
NAF 5 année 2018

Valuation method used

Net Income Multiple
124 336 € × 12.6x = 1 565 501 €
Range: 1 166 786€ - 2 574 884€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 177 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE 16 WILSON with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE 16 WILSON

What is the revenue of SELARL PHARMACIE 16 WILSON ?

The revenue of SELARL PHARMACIE 16 WILSON in 2016 is 1.1 M€.

Is SELARL PHARMACIE 16 WILSON profitable?

Yes, SELARL PHARMACIE 16 WILSON generated a net profit of 124 k€ in 2018.

Where is the headquarters of SELARL PHARMACIE 16 WILSON ?

The headquarters of SELARL PHARMACIE 16 WILSON is located in ANTIBES (06600), in the department Alpes-Maritimes.

Where to find the tax return of SELARL PHARMACIE 16 WILSON ?

The tax return of SELARL PHARMACIE 16 WILSON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE 16 WILSON operate?

SELARL PHARMACIE 16 WILSON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.